Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to -$129.8 million.

  • Acadia Healthcare Company's Cash from Investing Activities rose 3278.72% to -$129.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$667.1 million, marking a year-over-year decrease of 369.79%. This contributed to the annual value of -$736.5 million for FY2024, which is 8540.88% down from last year.
  • Latest data reveals that Acadia Healthcare Company reported Cash from Investing Activities of -$129.8 million as of Q3 2025, which was up 3278.72% from -$150.8 million recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year Cash from Investing Activities high stood at $1.4 billion for Q1 2021, and its period low was -$230.0 million during Q4 2021.
  • Its 5-year average for Cash from Investing Activities is -$46.9 million, with a median of -$110.2 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Acadia Healthcare Company's Cash from Investing Activities was 194410.0% (2021), while the steepest drop was 21862.71% (2021).
  • Over the past 5 years, Acadia Healthcare Company's Cash from Investing Activities (Quarter) stood at -$230.0 million in 2021, then skyrocketed by 59.99% to -$92.0 million in 2022, then dropped by 19.72% to -$110.2 million in 2023, then plummeted by 84.56% to -$203.3 million in 2024, then surged by 36.19% to -$129.8 million in 2025.
  • Its Cash from Investing Activities was -$129.8 million in Q3 2025, compared to -$150.8 million in Q2 2025 and -$183.2 million in Q1 2025.